Retina Labs Recognized as Innovator and Disruptor in Eye Healthcare

 In News

In its recent report entitled Disrupting Eye Healthcare, CB Insights delves into the emerging field of eye healthcare technologies. This report features a new breed of startups that are leveraging technology to disrupt eye care health by offering new (and usually less invasive) technologies to detect and treat common eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration. The report offers a concise snapshot of the eye health technology landscape and illustrates “how the eye can be a gateway to understanding full-body health”.

Retina Labs is excited to be one of a select group of companies mentioned in this report. Appearing in the category of Telemedicine/Telerefraction, Retina Labs has emerged a leader in the area of ocular telehealth. The company’s iVision teleophthalmology platform provides a complete, end-to-end cloud-based solution for early detection and management of eye disease. “Our solutions offer health systems and care providers a cost-effective means to close the care gap around diabetic eye disease”, says Richard Pridham, CEO of Retina Labs. “Diabetic retinopathy is the number one cause of blindness among the working-age population. Vision loss can be avoided through early detection and I’m delighted that we are playing an important role in preventing unnecessary blindness”, concludes Pridham.

CB Insights - Disrupting Eye Healthcare

CB Insights – Disrupting Eye Healthcare

To download your copy of the report visit:

About Retina Labs

For over a decade, Retina Labs has been on the leading edge of teleophthalmology innovation. Its cloud-based iVision teleophthalmology platform offers an integrated solution that combines advanced ocular imaging, clinical interpretation and reporting tools with electronic referrals. The company’s solutions allow healthcare providers to improve access to quality eye care while streamlining the processes related to the management of chronic eye diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration and retinopathy of prematurity. iVision is the teleophthalmology platform of choice for hospitals, health systems, primary care medical groups and ACOs and is recognized by the World Health Organization for its breakthrough advancements in telehealth technology. For more information on Retina Labs visit